BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 34990402)

  • 1. LC3-associated phagocytosis in bone marrow macrophages suppresses acute myeloid leukemia progression through STING activation.
    Moore JA; Mistry JJ; Hellmich C; Horton RH; Wojtowicz EE; Jibril A; Jefferson M; Wileman T; Beraza N; Bowles KM; Rushworth SA
    J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 34990402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taking the STING out of acute myeloid leukemia through macrophage-mediated phagocytosis.
    Dalton WB; Ghiaur G; Resar LM
    J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 35229728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
    Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
    Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC3-Associated Phagocytosis in Myeloid Cells Promotes Tumor Immune Tolerance.
    Cunha LD; Yang M; Carter R; Guy C; Harris L; Crawford JC; Quarato G; Boada-Romero E; Kalkavan H; Johnson MDL; Natarajan S; Turnis ME; Finkelstein D; Opferman JT; Gawad C; Green DR
    Cell; 2018 Oct; 175(2):429-441.e16. PubMed ID: 30245008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways.
    Bakhtiyari M; Liaghat M; Aziziyan F; Shapourian H; Yahyazadeh S; Alipour M; Shahveh S; Maleki-Sheikhabadi F; Halimi H; Forghaniesfidvajani R; Zalpoor H; Nabi-Afjadi M; Pornour M
    Cell Commun Signal; 2023 Sep; 21(1):252. PubMed ID: 37735675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bone marrow microenvironment - Home of the leukemic blasts.
    Shafat MS; Gnaneswaran B; Bowles KM; Rushworth SA
    Blood Rev; 2017 Sep; 31(5):277-286. PubMed ID: 28318761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIGIT blockade repolarizes AML-associated TIGIT
    Brauneck F; Fischer B; Witt M; Muschhammer J; Oelrich J; da Costa Avelar PH; Tsoka S; Bullinger L; Seubert E; Smit DJ; Bokemeyer C; Ackermann C; Wellbrock J; Haag F; Fiedler W
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36549780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment.
    Abdul-Aziz AM; Sun Y; Hellmich C; Marlein CR; Mistry J; Forde E; Piddock RE; Shafat MS; Morfakis A; Mehta T; Di Palma F; Macaulay I; Ingham CJ; Haestier A; Collins A; Campisi J; Bowles KM; Rushworth SA
    Blood; 2019 Jan; 133(5):446-456. PubMed ID: 30401703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
    Wang A; Zhong H
    Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells.
    Corradi G; Bassani B; Simonetti G; Sangaletti S; Vadakekolathu J; Fontana MC; Pazzaglia M; Gulino A; Tripodo C; Cristiano G; Bandini L; Ottaviani E; Ocadlikova D; Piccioli M; Martinelli G; Colombo MP; Rutella S; Cavo M; Ciciarello M; Curti A
    Clin Cancer Res; 2022 Jul; 28(14):3141-3155. PubMed ID: 35349670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplifying STING activation by bioinspired nanomedicine for targeted chemo- and immunotherapy of acute myeloid leukemia.
    Wang X; Huang R; Wu W; Xiong J; Wen Q; Zeng Y; Chen T; Li J; Zhang C; Zhong JF; Yang S; Zhang X
    Acta Biomater; 2023 Feb; 157():381-394. PubMed ID: 36375786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma cell-derived mtDAMPs activate the macrophage STING pathway, promoting myeloma progression.
    Jibril A; Hellmich C; Wojtowicz EE; Hampton K; Maynard R; De Silva R; Fowler-Shorten DJ; Mistry JJ; Moore JA; Bowles KM; Rushworth SA
    Blood; 2023 Jun; 141(25):3065-3077. PubMed ID: 36888932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3K inhibitor GDC-0941 enhances apoptotic effects of BH-3 mimetic ABT-737 in AML cells in the hypoxic bone marrow microenvironment.
    Jin L; Tabe Y; Kojima K; Shikami M; Benito J; Ruvolo V; Wang RY; McQueen T; Ciurea SO; Miida T; Andreeff M; Konopleva M
    J Mol Med (Berl); 2013 Dec; 91(12):1383-97. PubMed ID: 23955073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The non-cell-autonomous function of ID1 promotes AML progression via ANGPTL7 from the microenvironment.
    Fei MY; Wang Y; Chang BH; Xue K; Dong F; Huang D; Li XY; Li ZJ; Hu CL; Liu P; Wu JC; Yu PC; Hong MH; Chen SB; Xu CH; Chen BY; Jiang YL; Liu N; Zhao C; Jin JC; Hou D; Chen XC; Ren YY; Deng CH; Zhang JY; Zong LJ; Wang RJ; Gao FF; Liu H; Zhang QL; Wu LY; Yan J; Shen S; Chang CK; Sun XJ; Wang L
    Blood; 2023 Sep; 142(10):903-917. PubMed ID: 37319434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition.
    Saito K; Zhang Q; Yang H; Yamatani K; Ai T; Ruvolo V; Baran N; Cai T; Ma H; Jacamo R; Kuruvilla V; Imoto J; Kinjo S; Ikeo K; Moriya K; Suzuki K; Miida T; Kim YM; Vellano CP; Andreeff M; Marszalek JR; Tabe Y; Konopleva M
    Blood Adv; 2021 Oct; 5(20):4233-4255. PubMed ID: 34507353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia.
    Aru B; Pehlivanoğlu C; Dal Z; Dereli-Çalışkan NN; Gürlü E; Yanıkkaya-Demirel G
    Front Immunol; 2023; 14():1108200. PubMed ID: 36742324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Put in a "Ca
    Lewuillon C; Laguillaumie MO; Quesnel B; Idziorek T; Touil Y; Lemonnier L
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYLD stimulates macrophage phagocytosis of leukemic cells through STAT1 signalling in acute myeloid leukemia.
    Huyen NT; Ngoc NT; Giang NH; Trang DT; Hanh HH; Binh VD; Giang NV; Canh NX; Xuan NT
    PLoS One; 2023; 18(8):e0283586. PubMed ID: 37549179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of Acute Myeloid Leukemia Cells on the Proliferation and Apoptosis of Bone Marrow-Derived Mesenchymal Stromal Cells].
    Chen ZH; Zheng YX; Si JQ; Yuan T; Zhang ZR; Tian C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):430-434. PubMed ID: 35395975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRX1 Facilitates
    Huang JH; Liu CY; Wu SY; Chen WY; Chang TH; Kan HW; Hsieh ST; Ting JP; Wu-Hsieh BA
    Front Immunol; 2018; 9():2761. PubMed ID: 30559741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.